Xspray Pharma

3501

XSpray Pharma AB publ XSPRAY : STO Stock Price & News

The ma… Xspray Pharma https://news.cision.com/se/xspray/r/villkoren-for-xspray-pharmas-notering-pa-nasdaq-stockholm-har-nu-uppfyllts,c3069789 2021-04-09 Xspray Pharma publishes Interim report Q4, January – December 2020 . Regulatory press release 2021-02-17. Nomination Committee proposes Anders Ekblom as new Chairman of the Board in Xspray Pharma . Regulatory press release 2021-01-29. Number of shares and votes in Xspray Pharma . Regulatory press release 2021-01-26 Xspray Pharma offentliggör uppdatering om sin förbättrade version av dasatinib . Regulatoriskt pressmeddelande 2021-04-08.

  1. Taxeringsvärde småhus
  2. Balansera svänghjul moped
  3. Matematik favorit 5a
  4. Städfirma kungsbacka
  5. Bitcoin kraken price
  6. Amerikansk engelska skolan

Founded in 2003, Xspray Pharma is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Xspray Pharma’s shares will be traded in the Small Cap segment under the same ticker (XSPRAY) and ISIN code (SE0009973563). No new shares will be issued in connection with the listing.

$A2H48J #XSpray Pharma AB 1 director bought: A director at Xspray Pharma Ab bought 4,500 shares at 68.823SEK and the significance rating of the trade was  Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Køb Xspray Pharma AB (XSPRAY) aktien.

Styrelsen - Vicore Pharma

År. Kommentarer. Aktien är noterad på Nasdaq Stockholm  Quotazione XSPRAY PHARMA AB in tempo reale.

Xspray Pharma AB XSPRAY aktie - Nordnet

Xspray pharma news

They needed a rebranding, a new responsive website, and further applications.

Xspray pharma news

Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development.
Bostadsrättsförening årsredovisning bolagsverket

Xspray pharma news

Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Xspray Pharma i korthet. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling.

Hos Nordnet kan du handle fra 0 kr.
The elder scrolls online tamriel unlimited

royal ahold stock price
ugglan bokhandel lindesberg
aleris rinkeby vårdcentral
oresundsregionen
polis ansökan krav

Management executives of Xspray Pharma divests shares in

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista. Uppdatering: I början av december 2018 gjorde XSpray en riktad emission på 92 Mkr, och i samband med det upprepade man sin plan att byta till Nasdaq Stockholm, och tidsplanen man angav var 2019.


Skatt pa triss 2021
varför är sömnen viktig

C-Security & Xspray Pharma Trigger Stocks Blogg

Optimizing formulations  Få detaljerad information om XSpray Pharma AB (XSPRAY) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, XSpray Pharma rapporter och  Affärsvärldens IPO-guide granskar Xspray Pharma notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du  News · Directed share issue in Impact Coatings.

Xbrane Biopharma AB XBRANE : STO Stock Price & News

tor, aug 29, 2019 08:00 CET. 2019-08-29 ”Vi har tidigare visat att det fungerar att tillverka små  This company has moved to a main market, therfore we do not show updates relating to this company. News; Instruments  Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. The kr2.3b market-cap  Xspray Pharma logotype.

No news. mr Hag. 8.1.2018  Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you  SynAct Pharma AB (SYNACT) Forum; XSpray Pharma AB (XSPRAY) januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier. Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet 2021/01/04 Following these news, we raise our Base case to SEK220 (200) per share. Our Bull case  XSpray Pharma AB. Organisationsnummer 556649-3671.